Back to search
Hypoplastic Left Heart Syndrome
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Hypoplastic Left Heart Syndrome trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Hypoplastic Left Heart Syndrome trials you may qualify forCongenital heart disease (CHD) is the leading cause of congenital malformations, representing 1% of live births. Progress in surgical care have led to the drama…
This protocol is a research study involving human subjects diagnosed with Congenital Heart Defects/Disease (CHD). The Co-Op @ HeartWorks is a cooperative betwee…
The purpose of this study is to evaluate the efficacy and safety of intracoronary injection of JRM-001 after reconstructive surgery in pediatric patients with f…
A single arm clinical trial evaluating the safety and efficacy of the second generation TEVG as vascular conduits for extracardiac total cavopulmonary connectio…
The purpose of this initiative is to improve care and outcomes for infants with HLHS by expanding the NPC-QIC national registry to gather clinical care process,…
Neonatal patients with congenital heart defects (CHD) have changing physiology in the context of transitional period. Patients with CHD are at risk of low perfu…
The purpose of this research is to investigate the best way to manage evolving hypoplastic left heart syndrome (HLHS).
The objectives of this pilot study are to evaluate the feasibility and safety of intramyocardial injection of autologous c-kit+ cells during the Stage II Bidire…
The goal of this clinical trial is to learn if 3D-printed heart models and augmented reality can be useful modalities to teach medical students about congenital…